Niacin mimetics, and methods of use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8937063
SERIAL NO

13168629

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are heterocyclylalkyl-substituted and heteroaralkyl-substituted pyridines, and pharmaceutically acceptable salts and prodrugs thereof, that are active against a range of mammalian therapeutic indications.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ARISAPH PHARMACEUTICALS INC155 FEDERAL STREET SUITE 1602 BOSTON MA 02110

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bachovchin, William W Cambridge, US 98 1034
Kiritsy, Christopher P Waban, US 5 3
Lai, Hung-sen Andover, US 66 215
O'Connell, Daniel P Boston, US 7 34
Wu, Wengen Medford, US 40 105

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 20, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00